New York & Company Raised Following Celeb Signing and 4 Stock Analyses Attracting Attention
Fidelity National Information Services, Inc. (NYSE:FIS): Current Price: $37.44
FIS decided to keep its long-term growth targets and provided in-line FY13 EPS guidance, influencing Oppenheimer to believe that the stock has the ability to keep offering annual returns in the mid-teen percentage level, and it keeps its Outperform rating on the stock.
LMI Aerospace Inc. (NASDAQ:LMIA): Current Price: $22.33
The company’s price target has been raised by Oppenheimer as a way to reflect the company’s acquisition of Valeant, and its debt refinancing. The firm believes that the Valeant deal will be modestly accretive during the year and significantly accretive in 2014. It keeps its Outperform rating on the stock.
Are these stocks a buy or sell? Let us help you decide. Check out our Stock Picker Newsletter now.
New York & Company Inc. (NYSE:NWY): Current Price: $4.35
Brean Capital decided to raise its estimates on New York & Co. after it named Eve Mendes to act as an ambassador for the company. The firm thinks that the company revealed that it is prepared to return to prominence, they are comfortable with their fashion strategies, and Eve Mendes is to release her own clothing line. Brean Capital thinks that the future is now for New York & Co and would be aggressive buyers. Shares have a Buy rating and a $6 price target.
PROS Holdings, Inc. (NYSE:PRO): Current Price: $27.21
The company’s price target has been raised by Stifel Nicolaus after the company reported stronger than expected Q4 results and bookings that were ahead of plan. The firm is convinced that the positive momentum of the company’s B2B business is continuing, and it reiterates its Buy rating on the stock.
Salix Pharmaceuticals Ltd. (NASDAQ:SLXP): Current Price: $48.41
The firm received a subpoena concerning the sales and marketing practices for three of its drugs, and Wells Fargo does not think that the subpoenas will have a significant impact on the company’s underlying operations. The firm reiterates its Outperform rating on the stock.